On Friday, Ovid Therapeutics Inc (NASDAQ: OVID) opened higher 14.75% from the last session, before settling in for the closing price of $1.22. Price fluctuations for OVID have ranged from $0.24 to $2.01 over the past 52 weeks.
Healthcare Sector giant saw their annual sales surged by 24.72% over the last five years. Company’s average yearly earnings per share was noted -27.63% at the time writing. With a float of $59.63 million, this company’s outstanding shares have now reached $71.15 million.
Ovid Therapeutics Inc (OVID) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Ovid Therapeutics Inc is 16.27%, while institutional ownership is 40.38%. The most recent insider transaction that took place on Feb 26 ’25, was worth 2,956. In this transaction President and COO of this company sold 5,279 shares at a rate of $0.56, taking the stock ownership to the 73,406 shares. Before that another transaction happened on Feb 26 ’25, when Company’s CBFO sold 3,902 for $0.56, making the entire transaction worth $2,185. This insider now owns 67,973 shares in total.
Ovid Therapeutics Inc (OVID) Recent Fiscal highlights
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -0.13 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.17) by 0.04. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.09 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -27.63% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -13.20% during the next five years compared to 24.72% growth over the previous five years of trading.
Ovid Therapeutics Inc (NASDAQ: OVID) Trading Performance Indicators
Check out the current performance indicators for Ovid Therapeutics Inc (OVID). In the past quarter, the stock posted a quick ratio of 4.24. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 15.08.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.51, a number that is poised to hit -0.12 in the next quarter and is forecasted to reach -0.44 in one year’s time.
Technical Analysis of Ovid Therapeutics Inc (OVID)
Analysing the last 5-days average volume posted by the [Ovid Therapeutics Inc, OVID], we can find that recorded value of 1.24 million was lower than the volume posted last year of 1.5 million. As of the previous 9 days, the stock’s Stochastic %D was 54.11%.
During the past 100 days, Ovid Therapeutics Inc’s (OVID) raw stochastic average was set at 63.78%, which indicates a significant decrease from 86.27% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1177 in the past 14 days, which was higher than the 0.1163 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.4443, while its 200-day Moving Average is $0.7448. Now, the first resistance to watch is $1.4633. This is followed by the second major resistance level at $1.5267. The third major resistance level sits at $1.6433. If the price goes on to break the first support level at $1.2833, it is likely to go to the next support level at $1.1667. Now, if the price goes above the second support level, the third support stands at $1.1033.
Ovid Therapeutics Inc (NASDAQ: OVID) Key Stats
There are currently 71,212K shares outstanding in the company with a market cap of 99.70 million. Presently, the company’s annual sales total 570 K according to its annual income of -26,430 K. Last quarter, the company’s sales amounted to 130 K and its income totaled -12,160 K.
